US FDA's Biologics Center Director Expects It Soon Will See 'Growth Spurt'

Peter Marks isn't sure when it will arrive, but he expects that in the coming years the Center for Biologics Evaluation and Research will need more personnel and resources to handle an expanding workload.

Marks, CBER's director, said in an June 27 interview with the Pink Sheet that his center "may have a certain...